Recent developments with Agilon Health Inc (AGL) have led to the company’s beta value being reach 0.54 cents.

Agilon Health Inc (NYSE: AGL) kicked off on Friday, up 1.49% from the previous trading day, before settling in for the closing price of $5.38. Over the past 52 weeks, AGL has traded in a range of $4.41-$28.38.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Annual sales at Healthcare sector company grew by 53.71% over the past five years. While this was happening, its average annual earnings per share was recorded 33.75%. With a float of $301.79 million, this company’s outstanding shares have now reached $406.39 million.

Let’s look at the performance matrix of the company that is accounted for 1117 employees.

Agilon Health Inc (AGL) Insider and Institutional Ownership

Our next focus will be how large-scale investors are participating in this stock of the Medical Care Facilities Industry. The insider ownership of Agilon Health Inc is 26.12%, while institutional ownership is 85.76%. The most recent insider transaction that took place on Nov 29 ’23, was worth 250,206. In this transaction Director of this company bought 22,300 shares at a rate of $11.22, taking the stock ownership to the 31,931 shares. Before that another transaction happened on Sep 13 ’23, when Company’s Chief Markets Officer sold 18,750 for $18.00, making the entire transaction worth $337,455. This insider now owns 79,543 shares in total.

Agilon Health Inc (AGL) Latest Financial update

Wall Street market experts anticipate that the next fiscal year will bring earnings of 83.23 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 33.75% per share during the next fiscal year.

Agilon Health Inc (NYSE: AGL) Trading Performance Indicators

Take a look at Agilon Health Inc’s (AGL) current performance indicators. Last quarter, stock had a quick ratio of 1.51. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.49.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.53, a number that is poised to hit -0.01 in the next quarter and is forecasted to reach -0.15 in one year’s time.

Technical Analysis of Agilon Health Inc (AGL)

Agilon Health Inc (NYSE: AGL) saw its 5-day average volume 6.23 million, a positive change from its year-to-date volume of 5.91 million. As of the previous 9 days, the stock’s Stochastic %D was 68.47%. Additionally, its Average True Range was 0.45.

During the past 100 days, Agilon Health Inc’s (AGL) raw stochastic average was set at 11.23%, which indicates a significant decrease from 77.78% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 113.82% in the past 14 days, which was higher than the 95.06% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $5.77, while its 200-day Moving Average is $12.49. Nevertheless, the first resistance level for the watch stands at $5.72 in the near term. At $5.98, the stock is likely to face the second major resistance level. The third major resistance level sits at $6.21. If the price goes on to break the first support level at $5.24, it is likely to go to the next support level at $5.01. The third support level lies at $4.75 if the price breaches the second support level.

Agilon Health Inc (NYSE: AGL) Key Stats

The company with the Market Capitalisation of 2.24 billion has total of 409,542K Shares Outstanding. Its annual sales at the moment are 4,316 M in contrast with the sum of -262,600 K annual income. Company’s last quarter sales were recorded 815,500 K and last quarter income was -230,430 K.